1-nitropyrene increases expression ISO RGD:733283 6480464 1-nitropyrene results in increased expression of ALCAM mRNA CTD PMID:19041380 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of ALCAM mRNA CTD PMID:20170705 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of ALCAM mRNA CTD PMID:15834898 , PMID:17557909 17alpha-ethynylestradiol increases expression ISO RGD:733284 6480464 Ethinyl Estradiol results in increased expression of ALCAM mRNA CTD PMID:17942748 17beta-estradiol affects expression ISO RGD:733283 6480464 Estradiol affects the expression of ALCAM mRNA CTD PMID:14699072 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of ALCAM mRNA CTD PMID:26496021 17beta-estradiol decreases expression ISO RGD:733283 6480464 Estradiol results in decreased expression of ALCAM mRNA CTD PMID:19619570 , PMID:21185374 17beta-estradiol increases expression ISO RGD:733284 6480464 Estradiol results in increased expression of ALCAM mRNA CTD PMID:15289156 17beta-estradiol multiple interactions ISO RGD:733283 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of ALCAM mRNA, Raloxifene Hydrochloride inhibits the reaction [Estradiol results in decreased expression of ALCAM mRNA] CTD PMID:19619570 , PMID:21185374 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:16984957 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:733284 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733283 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of ALCAM mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:733284 6480464 Tetrachlorodibenzodioxin affects the expression of ALCAM mRNA CTD PMID:21570461 , PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ALCAM mRNA CTD PMID:21215274 , PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:733283 6480464 Tetrachlorodibenzodioxin affects the expression of ALCAM mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733284 6480464 Tetrachlorodibenzodioxin results in increased expression of ALCAM mRNA CTD PMID:19684285 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:733284 6480464 Tetrachlorodibenzodioxin results in decreased expression of ALCAM mRNA CTD PMID:19465110 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:733283 6480464 Tetrachlorodibenzodioxin results in decreased expression of ALCAM mRNA CTD PMID:19619570 , PMID:19684285 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733283 6480464 Tetrachlorodibenzodioxin results in increased expression of ALCAM mRNA CTD PMID:19684285 2,4-diaminotoluene increases expression ISO RGD:733284 6480464 2, 4-diaminotoluene results in increased expression of ALCAM mRNA CTD PMID:20713471 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of ALCAM mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of ALCAM mRNA CTD PMID:21346803 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:16984957 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:20959002 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:733284 6480464 tetrabromobisphenol A results in increased expression of ALCAM mRNA CTD PMID:25172293 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of ALCAM mRNA CTD PMID:30071829 3-methylcholanthrene increases expression ISO RGD:733284 6480464 Methylcholanthrene results in increased expression of ALCAM mRNA CTD PMID:20713471 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of ALCAM mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol increases expression ISO RGD:733284 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ALCAM mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO RGD:733284 6480464 Fenretinide results in decreased expression of ALCAM mRNA CTD PMID:28973697 5-fluorouracil affects response to substance ISO RGD:733283 6480464 ALCAM protein affects the susceptibility to Fluorouracil CTD PMID:15352031 5-fluorouracil decreases expression ISO RGD:733283 6480464 Fluorouracil results in decreased expression of ALCAM protein CTD PMID:15352031 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of ALCAM mRNA CTD PMID:31881176 aflatoxin B1 decreases methylation ISO RGD:733283 6480464 Aflatoxin B1 results in decreased methylation of ALCAM gene CTD PMID:27153756 aldehydo-D-glucose multiple interactions ISO RGD:733284 6480464 fucoxanthin inhibits the reaction [Glucose results in increased expression of ALCAM mRNA] CTD PMID:33448797 aldehydo-D-glucose increases expression ISO RGD:733284 6480464 Glucose results in increased expression of ALCAM mRNA CTD PMID:33448797 all-trans-retinoic acid increases expression ISO RGD:733283 6480464 Tretinoin results in increased expression of ALCAM mRNA CTD PMID:21934132 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ALCAM mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:733283 6480464 Antirheumatic Agents results in decreased expression of ALCAM mRNA CTD PMID:24449571 aristolochic acid decreases expression ISO RGD:733283 6480464 aristolochic acid I results in decreased expression of ALCAM mRNA, aristolochic acid I results in decreased expression of ALCAM protein CTD PMID:33212167 Aroclor 1254 decreases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of ALCAM mRNA CTD PMID:18178546 benzo[a]pyrene decreases expression ISO RGD:733284 6480464 Benzo(a)pyrene results in decreased expression of ALCAM mRNA CTD PMID:19770486 benzo[a]pyrene increases expression ISO RGD:733283 6480464 Benzo(a)pyrene results in increased expression of ALCAM protein CTD PMID:32717239 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:733283 6480464 7 more ... CTD PMID:19150397 benzoates decreases expression ISO RGD:733283 6480464 Benzoates analog results in decreased expression of ALCAM mRNA CTD PMID:29472718 bisphenol A affects expression ISO RGD:733283 6480464 bisphenol A affects the expression of ALCAM mRNA CTD PMID:20170705 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ALCAM mRNA CTD PMID:30816183 bisphenol A increases expression ISO RGD:733284 6480464 bisphenol A results in increased expression of ALCAM mRNA CTD PMID:30951980 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ALCAM protein CTD PMID:24552547 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of ALCAM mRNA CTD PMID:26496021 bisphenol F increases expression ISO RGD:733284 6480464 bisphenol F results in increased expression of ALCAM mRNA CTD PMID:30951980 Brodifacoum decreases expression EXP 6480464 bromfenacoum results in decreased expression of ALCAM protein CTD PMID:28903499 cadmium atom increases expression ISO RGD:733284 6480464 Cadmium results in increased expression of ALCAM mRNA CTD PMID:24067728 cadmium dichloride increases expression ISO RGD:733283 6480464 Cadmium Chloride results in increased expression of ALCAM mRNA CTD PMID:26472689 cannabidiol decreases expression ISO RGD:733283 6480464 Cannabidiol results in decreased expression of ALCAM mRNA CTD PMID:27932991 carbon nanotube decreases secretion ISO RGD:733284 6480464 Nanotubes, Carbon results in decreased secretion of ALCAM protein CTD PMID:25598225 carbon nanotube decreases expression ISO RGD:733284 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 chlordecone increases expression ISO RGD:733284 6480464 Chlordecone results in increased expression of ALCAM mRNA CTD PMID:33711761 chloropicrin increases expression ISO RGD:733283 6480464 chloropicrin results in increased expression of ALCAM mRNA CTD PMID:26352163 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of ALCAM mRNA CTD PMID:18668222 clobetasol decreases expression ISO RGD:733284 6480464 Clobetasol results in decreased expression of ALCAM mRNA CTD PMID:27462272 cocaine increases expression EXP 6480464 Cocaine results in increased expression of ALCAM mRNA CTD PMID:17898221 copper atom decreases expression EXP 6480464 Copper results in decreased expression of ALCAM mRNA CTD PMID:30556269 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of ALCAM mRNA CTD PMID:30556269 coumestrol decreases expression ISO RGD:733283 6480464 Coumestrol results in decreased expression of ALCAM mRNA CTD PMID:19167446 curcumin decreases expression ISO RGD:733283 6480464 Curcumin results in decreased expression of ALCAM mRNA CTD PMID:33539684 cyclophosphamide increases expression ISO RGD:733284 6480464 Cyclophosphamide results in increased expression of ALCAM mRNA CTD PMID:21041162 cyclosporin A affects expression ISO RGD:733284 6480464 Cyclosporine affects the expression of ALCAM mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO RGD:733283 6480464 Cyclosporine results in decreased expression of ALCAM mRNA CTD PMID:25562108 , PMID:27989131 D-glucose multiple interactions ISO RGD:733284 6480464 fucoxanthin inhibits the reaction [Glucose results in increased expression of ALCAM mRNA] CTD PMID:33448797 D-glucose increases expression ISO RGD:733284 6480464 Glucose results in increased expression of ALCAM mRNA CTD PMID:33448797 DDT decreases expression EXP 6480464 DDT results in decreased expression of ALCAM mRNA CTD PMID:30207508 dexamethasone increases expression ISO RGD:733284 6480464 Dexamethasone results in increased expression of ALCAM mRNA CTD PMID:21041162 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of ALCAM mRNA CTD PMID:21266533 dibutyl phthalate increases expression ISO RGD:733284 6480464 Dibutyl Phthalate results in increased expression of ALCAM mRNA CTD PMID:17361019 , PMID:21266533 dicrotophos decreases expression ISO RGD:733283 6480464 dicrotophos results in decreased expression of ALCAM mRNA CTD PMID:28302478 diethylstilbestrol increases expression ISO RGD:733284 6480464 Diethylstilbestrol results in increased expression of ALCAM mRNA CTD PMID:15289156 diuron decreases expression EXP 6480464 Diuron results in decreased expression of ALCAM mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:733283 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 elemental selenium decreases expression ISO RGD:733283 6480464 Selenium results in decreased expression of ALCAM mRNA CTD PMID:19244175 enzyme inhibitor multiple interactions ISO RGD:733283 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ALCAM protein CTD PMID:23301498 ethanol multiple interactions ISO RGD:733284 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of ALCAM mRNA CTD PMID:30517762 folic acid decreases expression ISO RGD:733284 6480464 Folic Acid results in decreased expression of ALCAM mRNA CTD PMID:25629700 fonofos increases methylation ISO RGD:733283 6480464 Fonofos results in increased methylation of ALCAM promoter CTD PMID:22847954 fucoxanthin multiple interactions ISO RGD:733284 6480464 fucoxanthin inhibits the reaction [Glucose results in increased expression of ALCAM mRNA] CTD PMID:33448797 fumonisin B1 increases expression ISO RGD:733284 6480464 fumonisin B1 results in increased expression of ALCAM mRNA CTD PMID:16221962 genistein increases expression ISO RGD:733284 6480464 Genistein results in increased expression of ALCAM mRNA CTD PMID:15289156 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ALCAM mRNA CTD PMID:33387578 glucose increases expression ISO RGD:733284 6480464 Glucose results in increased expression of ALCAM mRNA CTD PMID:33448797 glucose multiple interactions ISO RGD:733284 6480464 fucoxanthin inhibits the reaction [Glucose results in increased expression of ALCAM mRNA] CTD PMID:33448797 heptachlor decreases expression EXP 6480464 Heptachlor results in decreased expression of ALCAM mRNA CTD PMID:23153324 isotretinoin decreases expression ISO RGD:733283 6480464 Isotretinoin results in decreased expression of ALCAM mRNA CTD PMID:20436886 ivermectin decreases expression ISO RGD:733283 6480464 Ivermectin results in decreased expression of ALCAM protein CTD PMID:32959892 lead diacetate increases expression ISO RGD:733284 6480464 lead acetate results in increased expression of ALCAM mRNA CTD PMID:21829687 lead(0) affects splicing ISO RGD:733283 6480464 Lead affects the splicing of ALCAM mRNA CTD PMID:28903495 lead(2+) affects splicing ISO RGD:733283 6480464 Lead affects the splicing of ALCAM mRNA CTD PMID:28903495 medroxyprogesterone acetate increases expression ISO RGD:733283 6480464 Medroxyprogesterone Acetate results in increased expression of ALCAM mRNA CTD PMID:18497975 , PMID:20843944 mercury dibromide increases expression ISO RGD:733283 6480464 mercuric bromide results in increased expression of ALCAM mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:733283 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALCAM mRNA CTD PMID:27188386 methyl methanesulfonate decreases expression ISO RGD:733283 6480464 Methyl Methanesulfonate results in decreased expression of ALCAM mRNA CTD PMID:23649840 methylmercury chloride affects expression ISO RGD:733284 6480464 methylmercuric chloride affects the expression of ALCAM mRNA CTD PMID:21613230 methylmercury chloride decreases expression ISO RGD:733283 6480464 methylmercuric chloride results in decreased expression of ALCAM mRNA CTD PMID:28001369 methylmercury chloride increases expression ISO RGD:733283 6480464 methylmercuric chloride results in increased expression of ALCAM mRNA CTD PMID:23179753 miconazole decreases expression ISO RGD:733284 6480464 Miconazole results in decreased expression of ALCAM mRNA CTD PMID:27462272 mitomycin C affects response to substance ISO RGD:733283 6480464 ALCAM protein affects the susceptibility to Mitomycin CTD PMID:16217747 Muraglitazar decreases expression EXP 6480464 muraglitazar results in decreased expression of ALCAM mRNA CTD PMID:21515302 N-acetyl-1,4-benzoquinone imine affects response to substance ISO RGD:733283 6480464 ALCAM gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine CTD PMID:21177773 N-methyl-4-phenylpyridinium decreases expression ISO RGD:733283 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of ALCAM mRNA CTD PMID:24810058 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of ALCAM mRNA CTD PMID:28801915 N-nitrosodiethylamine increases expression ISO RGD:733284 6480464 Diethylnitrosamine results in increased expression of ALCAM mRNA CTD PMID:24535843 nickel sulfate increases expression ISO RGD:733283 6480464 nickel sulfate results in increased expression of ALCAM mRNA CTD PMID:16780908 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of ALCAM mRNA CTD PMID:24136188 panobinostat increases expression ISO RGD:733283 6480464 panobinostat results in increased expression of ALCAM mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:733283 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALCAM mRNA CTD PMID:27188386 paracetamol affects expression ISO RGD:733284 6480464 Acetaminophen affects the expression of ALCAM mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ALCAM mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:733284 6480464 Acetaminophen results in increased expression of ALCAM mRNA CTD PMID:29246445 paracetamol multiple interactions ISO RGD:733284 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of ALCAM mRNA] CTD PMID:29246445 paracetamol decreases expression ISO RGD:733283 6480464 Acetaminophen results in decreased expression of ALCAM mRNA CTD PMID:21420995 parathion increases methylation ISO RGD:733283 6480464 Parathion results in increased methylation of ALCAM promoter CTD PMID:22847954 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of ALCAM mRNA CTD PMID:18692542 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:733283 6480464 perfluorooctane sulfonic acid results in decreased expression of ALCAM mRNA CTD PMID:27153767 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of ALCAM mRNA CTD PMID:19162173 phenobarbital decreases expression ISO RGD:733284 6480464 Phenobarbital results in decreased expression of ALCAM mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO RGD:733283 6480464 Phenylmercuric Acetate results in increased expression of ALCAM mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:733283 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALCAM mRNA CTD PMID:27188386 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of ALCAM mRNA CTD PMID:19162173 , PMID:22484513 pirinixic acid decreases expression ISO RGD:733284 6480464 pirinixic acid results in decreased expression of ALCAM mRNA CTD PMID:23811191 progesterone increases expression ISO RGD:733283 6480464 Progesterone results in increased expression of ALCAM mRNA CTD PMID:18497975 , PMID:21795739 propiconazole decreases expression ISO RGD:733284 6480464 propiconazole results in decreased expression of ALCAM mRNA CTD PMID:21278054 protein kinase inhibitor multiple interactions ISO RGD:733283 6480464 Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of ALCAM mRNA] CTD PMID:28003376 raloxifene multiple interactions ISO RGD:733283 6480464 Raloxifene Hydrochloride inhibits the reaction [Estradiol results in decreased expression of ALCAM mRNA] CTD PMID:21185374 SB 431542 increases expression ISO RGD:733283 6480464 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of ALCAM protein CTD PMID:25670856 SB 431542 multiple interactions ISO RGD:733283 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom decreases expression ISO RGD:733283 6480464 Selenium results in decreased expression of ALCAM mRNA CTD PMID:19244175 silver atom increases expression ISO RGD:733284 6480464 Silver results in increased expression of ALCAM mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:733284 6480464 Silver results in increased expression of ALCAM mRNA CTD PMID:27131904 sodium arsenate increases expression ISO RGD:733284 6480464 sodium arsenate results in increased expression of ALCAM mRNA CTD PMID:21795629 sodium arsenite decreases expression ISO RGD:733283 6480464 sodium arsenite results in decreased expression of ALCAM protein CTD PMID:21925251 sodium fluoride decreases expression ISO RGD:733284 6480464 Sodium Fluoride results in decreased expression of ALCAM protein CTD PMID:28918527 succimer multiple interactions ISO RGD:733284 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ALCAM mRNA CTD PMID:21641980 sulforaphane decreases expression ISO RGD:733283 6480464 sulforaphane results in decreased expression of ALCAM mRNA CTD PMID:31838189 sunitinib increases expression ISO RGD:733283 6480464 Sunitinib results in increased expression of ALCAM mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:733283 6480464 Tamoxifen affects the expression of ALCAM mRNA CTD PMID:14699072 temozolomide decreases expression ISO RGD:733283 6480464 Temozolomide results in decreased expression of ALCAM mRNA CTD PMID:31758290 terbufos increases methylation ISO RGD:733283 6480464 terbufos results in increased methylation of ALCAM promoter CTD PMID:22847954 Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of ALCAM mRNA CTD PMID:21515302 tetrachloromethane affects expression ISO RGD:733284 6480464 Carbon Tetrachloride affects the expression of ALCAM mRNA CTD PMID:17484886 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of ALCAM mRNA CTD PMID:31150632 tetrachloromethane multiple interactions ISO RGD:733284 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of ALCAM mRNA CTD PMID:30517762 tetrachloromethane increases expression ISO RGD:733284 6480464 Carbon Tetrachloride results in increased expression of ALCAM mRNA CTD PMID:27339419 , PMID:31919559 thapsigargin increases expression ISO RGD:733283 6480464 Thapsigargin results in increased expression of ALCAM mRNA CTD PMID:22378314 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ALCAM mRNA CTD PMID:23411599 titanium dioxide increases expression ISO RGD:733284 6480464 titanium dioxide results in increased expression of ALCAM mRNA CTD PMID:23409001 toluene increases expression EXP 6480464 Toluene results in increased expression of ALCAM mRNA CTD PMID:22967744 topotecan increases expression EXP 6480464 Topotecan results in increased expression of ALCAM mRNA CTD PMID:25729387 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of ALCAM mRNA CTD PMID:19448997 , PMID:33387578 trichostatin A increases expression ISO RGD:733283 6480464 trichostatin A results in increased expression of ALCAM mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:733283 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALCAM mRNA CTD PMID:27188386 trimellitic anhydride increases expression ISO RGD:733284 6480464 trimellitic anhydride results in increased expression of ALCAM mRNA CTD PMID:19042947 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of ALCAM mRNA CTD PMID:30589522 troglitazone decreases expression ISO RGD:733284 6480464 troglitazone results in decreased expression of ALCAM mRNA CTD PMID:28973697 valproic acid affects expression ISO RGD:733283 6480464 Valproic Acid affects the expression of ALCAM mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:733283 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALCAM mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:733283 6480464 Valproic Acid results in increased expression of ALCAM mRNA CTD PMID:23179753 more ... venlafaxine hydrochloride increases expression EXP 6480464 Venlafaxine Hydrochloride results in increased expression of ALCAM mRNA CTD PMID:25423262 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of ALCAM mRNA CTD PMID:23034163 , PMID:23555832 vorinostat increases expression ISO RGD:733283 6480464 vorinostat results in increased expression of ALCAM mRNA CTD PMID:26272509 , PMID:27188386 vorinostat multiple interactions ISO RGD:733283 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALCAM mRNA CTD PMID:27188386
